Medical and Pharmaceutical Portage Biotech soars after initiating proceedings for iOx Therapeutics sale The stock went up by over 185% after the LOI was announced Rowan DunneDecember 17, 2024
Medical and Pharmaceutical Sagimet Biosciences up 30% on strong clinical stage data Denifanstat received FDA Breakthrough Therapy designation for metabolic dysfunction-associated steatohepatitis Joseph MortonDecember 16, 2024
Medical and Pharmaceutical Cizzle Biotechnology expands lung cancer blood biopsy test distribution into Caribbean This UK oncology company was spun out from the University of York's Department of Biology Rowan DunneDecember 16, 2024
Medical and Pharmaceutical Immutep starts multinational Phase III lung cancer drug trial at 150 sites It will examine the efficacy of 'eftilagimod alfa' in conjunction with Merck's Keytruda drug and chemo Rowan DunneDecember 12, 2024
Medical and Pharmaceutical BioAge Labs craters after dropping clinical study on top drug candidate for obesity Usage of the therapeutic resulted in unhealthy levels of transaminases (liver enzymes) in participants Rowan DunneDecember 9, 2024
Medical and Pharmaceutical University of Cambridge develops ‘zombie cell’ detecting lung cancer urine test It is not the first pee test used to help diagnose the disease, but it is the first of its kind Rowan DunneDecember 6, 2024
Medical and Pharmaceutical Janux Therapeutics soars on clinical trial data for prostate cancer treatment candidate For 63 per cent of patients, the cancer was either reduced or kept from worsening Joseph MortonDecember 3, 2024
Medical and Pharmaceutical AI lung cancer screening tech developer, Imidex, seeks buyer at Chicago conference Its 'VisiRad XR' X-ray assessment system is FDA-approved and assisted by Google Cloud's Vertex AI platform Rowan DunneDecember 2, 2024
Medical and Pharmaceutical Kentucky governor recognizes Lung Cancer Awareness Month with formal proclamation Kentucky has the highest rate of the disease in the country, largely attributable to a vast number of smokers Rowan DunneNovember 26, 2024
Medical and Pharmaceutical Neurogene patient dies in drug trial, stock surges after FDA says ‘use lower dose’ This unfortunate incident occurred during a study on the company's Rett syndrome therapeutic NGN-401 Rowan DunneNovember 22, 2024